Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127346861 | 12734686 | 1 | I | 2016 | 20160803 | 20160913 | 20160913 | PER | US-ASTRAZENECA-2016SE84871 | ASTRAZENECA | 59.00 | YR | F | Y | 117.50000 | KG | 20160913 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127346861 | 12734686 | 1 | PS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | DAILY | 19962 | MODIFIED-RELEASE TABLET | |||||||||
| 127346861 | 12734686 | 2 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | Oral | DAILY | 19962 | MODIFIED-RELEASE TABLET | |||||||||
| 127346861 | 12734686 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | BID | ||||||||
| 127346861 | 12734686 | 4 | SS | BRILINTA | TICAGRELOR | 1 | Oral | 0 | TABLET | ||||||||||
| 127346861 | 12734686 | 5 | C | ASPIRIN. | ASPIRIN | 1 | 0 | 81 | MG | QD | |||||||||
| 127346861 | 12734686 | 6 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 1000.0MG UNKNOWN | 0 | 1000 | MG | |||||||||
| 127346861 | 12734686 | 7 | C | LOSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
| 127346861 | 12734686 | 8 | C | INSULIN | INSULIN NOS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127346861 | 12734686 | 1 | Blood pressure abnormal |
| 127346861 | 12734686 | 2 | Cardiac disorder |
| 127346861 | 12734686 | 3 | Dyspepsia |
| 127346861 | 12734686 | 4 | Stent placement |
| 127346861 | 12734686 | 5 | Adjuvant therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127346861 | 12734686 | Asthma | |
| 127346861 | 12734686 | Cough | |
| 127346861 | 12734686 | Dyspnoea | |
| 127346861 | 12734686 | Haemoptysis | |
| 127346861 | 12734686 | Headache | |
| 127346861 | 12734686 | Hypersensitivity | |
| 127346861 | 12734686 | Intentional product misuse | |
| 127346861 | 12734686 | Oropharyngeal pain | |
| 127346861 | 12734686 | Pharyngeal oedema | |
| 127346861 | 12734686 | Productive cough | |
| 127346861 | 12734686 | Upper-airway cough syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127346861 | 12734686 | 1 | 2016 | 0 | ||
| 127346861 | 12734686 | 2 | 2016 | 0 | ||
| 127346861 | 12734686 | 4 | 20160405 | 0 | ||
| 127346861 | 12734686 | 5 | 201604 | 0 |